KVUEKenvue

$19.22
Kenvue logo

Price

$19.22-6.2%1Y
1M+1.7%1Y-6.2%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Above average
8/10
Value57
Quality75
Momentum57
Growth52
Strongest Quality, weakest Growth · ranked vs Consumer Defensive peers. The five questions below judge the company on its own terms.
What they do

At Kenvue, our purpose is to realize the extraordinary power of everyday care. As a global leader at the intersection of healthcare and consumer goods, we are the world’s largest pure-play consumer health company by revenue with $15.1 billion in Net sales in the fiscal year 2025. By combining the power of science with meaningful consumer insights and our digital strategy, we empower consumers to live healthier lives every day.

In the company’s own words · 10-K filed Feb 20, 2026 · SEC EDGAR

P/E (TTM)22.1
Market Cap$34.79B
1Y Return-6.2%
5Y Return-

Business segments

Q1 2026 · $3.91B

The company’s own SEC segment disclosure.

  • Self Care$1.70B43%
  • Essential Health$1.15B29%
  • Skin Health And Beauty$1.06B27%

Kenvue (KVUE) reported revenue of $3.96B in Q2 2026 (quarter ended June 28, 2026), up 3.0% from the same quarter a year earlier. That came with a gross margin of 58% and net income of $456M (12% of revenue). For the full year FY2025, revenue was $15.1B (−2.1% year on year) and net income $1.47B. Its largest segment in 2026-Q1 was Self Care at $1.70B, 43% of the disclosed total, just ahead of Essential Health at 29%.

Raw charts

11 series · TTM

As reported to the SEC, without any scoring.